SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kumaka Industries informs about outcome of board meeting

21 Jul 2021 Evaluate

Kumaka Industries has informed that the Board of Directors of the Company at its meeting held on 21st July, 2021, has approved following business: Approval to the standalone un-audited financial result for the Quarter ended 30th June, 2021 along with Limited Review Report is attached for reference and record, Approval to the Board’s Report and approval to the appointment of Nitil Kamble as an Independent Additional Director of the Company.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×